Welcome to our dedicated page for Plexus SEC filings (Ticker: PLXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Plexus Corp (NASDAQ: PLXS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Plexus files periodic and current reports as a Wisconsin corporation with Commission File Number 001-14423.
Among the key documents available are current reports on Form 8-K, which Plexus uses to furnish press releases announcing quarterly and annual financial results. These filings typically include information on revenue, operating margin, earnings per share, non-GAAP performance measures, return on invested capital, free cash flow and other financial metrics, as well as commentary on business conditions and program wins.
Through this page, users can track how Plexus reports its results for fiscal quarters and years, including references to its geographic segments in the Americas, Asia-Pacific and Europe, Middle East and Africa regions, and its focus on Aerospace/Defense, Healthcare/Life Sciences and Industrial market sectors. Filings also confirm corporate details such as state of incorporation and principal corporate location.
Stock Titan enhances these filings with AI-powered summaries that highlight the most important points from lengthy documents, helping readers quickly understand the implications of each report. Real-time updates from the SEC’s EDGAR system, along with structured access to forms such as 8-K and other periodic reports, make it easier to review Plexus’ regulatory history and monitor ongoing disclosures related to PLXS.
Plexus Corp regional executive granted stock units Victor Tan, Regional President - APAC of Plexus Corp, reported stock-based compensation awards rather than open-market trades. On February 9, 2026, he received 2,020 Restricted Stock Units that vest on February 9, 2029. He was also granted 2,840 Performance Stock Units, which may convert into an equal number of common shares if performance goals tied to total shareholder return and economic return over a three-year period are met or exceeded. Following these awards, he directly beneficially owned 11,435 shares of Plexus common stock.
Running Michael J. reported acquisition or exercise transactions in this Form 4 filing.
Plexus Corp regional president Michael J. Running reported equity awards tied to the company’s stock. On February 9, 2026, he received 1,100 Restricted Stock Units that each represent one share of common stock and vest on February 9, 2029.
He was also granted 1,550 Performance Stock Units, each tied to one share, with vesting based on a three-year performance period. Part of the award depends on relative total shareholder return versus the S&P 400 Index, and the rest on economic return goals. Following these awards, he directly held 1,295 common shares.
Ninivaggi Angelo Michael Jr reported acquisition or exercise transactions in this Form 4 filing.
Plexus Corp executive Angelo Michael Ninivaggi Jr., Exec VP, CAO, General Counsel and Secretary, reported new equity awards. On February 9, 2026 he was granted 2,300 restricted stock units, each representing one Plexus common share and vesting on February 9, 2029.
He was also granted 3,240 performance stock units, each tied to one Plexus common share if performance goals are met. Vesting for 940 PSUs depends on relative total shareholder return versus the S&P 400 Index, and the rest on economic return goals over a three-year period. Following these awards, he directly holds 20,099 common shares.
Plexus Corp executive vice president and COO Oliver K. Mihm reported equity awards tied to company stock. On February 9, 2026, he acquired 4,030 Restricted Stock Units under the Plexus Corp. 2024 Omnibus Incentive Plan, which vest on February 9, 2029.
He also acquired 5,670 Performance Stock Units, each representing a contingent right to one share of common stock if performance conditions are met. PSU vesting depends on relative total shareholder return versus the S&P 400 Index and economic return goals over a three-year performance period. Following the report, he holds 22,267 common shares directly and 981 shares through the Plexus 401(k) plan.
Kelsey Todd P. reported acquisition or exercise transactions in this Form 4 filing.
Plexus Corp. President & CEO Todd P. Kelsey received equity awards of 16,320 restricted stock units and 22,950 performance stock units on February 9, 2026. These awards give a contingent right to receive an equal number of Plexus common shares.
The restricted stock units vest on February 9, 2029. The performance stock units depend on a three-year performance period, with 6,630 units tied to relative total shareholder return versus the S&P 400 Index and the remainder tied to economic return goals. Following these awards, he directly beneficially owned 78,598 common shares.
Jermain Patrick John reported acquisition or exercise transactions in this Form 4 filing.
Plexus Corp. executive vice president and CFO Patrick J. Jermain reported equity awards and current share holdings. On February 9, 2026, he received a grant of 4,030 Restricted Stock Units under the 2024 Omnibus Incentive Plan, which vest on February 9, 2029.
He was also granted 5,670 Performance Stock Units, each representing a contingent right to one share of common stock based on total shareholder return versus the S&P 400 Index and economic return goals over a three-year performance period. Following these awards, he beneficially owns 16,882 shares of Plexus common stock directly and 3,751 shares indirectly through the company’s 401(k) Retirement Plan, in addition to the derivative unit holdings.
Plexus Corp regional president Victor Tan reported selling Plexus common stock in two open-market transactions on February 6, 2026. He sold 1,000 shares at $205.00 per share and 2,000 shares at $205.75 per share, with the latter price reported as a weighted average from trades between $205.50 and $206.00.
After these sales, Tan directly beneficially owned 11,435 Plexus shares. The filing notes he will provide full trade details, including individual prices and share amounts, to regulators, the company, or shareholders upon request.
Plexus Corp. chairman Dean A. Foate, a director and Chairman of the Board, reported insider transactions in Plexus Corp. common stock.
On February 6, 2026, he sold 10,000 shares of common stock at $205 per share, leaving him with 99,429 shares held directly. He also has 15,000 shares held indirectly in a trust for which he is trustee.
Separately, on February 9, 2026, he received a grant of 1,008 Restricted Stock Units under the Plexus Corp. 2024 Omnibus Incentive Plan. Each unit represents one share of common stock and these units vest on February 9, 2027.
Plexus Corp executive Angelo Michael Ninivaggi Jr., Exec VP, CAO, General Counsel and Secretary, reported a sale of Plexus common stock. On February 5, 2026, he sold 4,303 shares of common stock at a price of $203.06 per share. After this transaction, he directly beneficially owned 20,099 shares of Plexus common stock.
Plexus Corp. executive Patrick J. Jermain, Exec. VP & CFO, reported a sale of common stock. On February 4, 2026, he sold 3,587 shares of Plexus Corp. common stock at $204.09 per share.
After this transaction, he directly owned 16,882 shares of Plexus common stock. In addition, 3,719 shares were held indirectly in the Plexus Corp. 401(k) Retirement Plan, based on the latest report from the plan’s trustee.